Home Blog Page 483

Tejas Networks Launches Indigenous 64T64R Massive MIMO Radio at IMC 2025

Tejas Networks has launched its indigenously designed 64T64R Massive MIMO Radio, named Ojas64, at the India Mobile Congress (IMC) 2025 in New Delhi. The 5G Macro radio delivers up to 320W of output power, offering multi-gigabit speeds and significant spectral efficiency gains, while reducing its carbon footprint. The launch was attended by government dignitaries, highlighting India’s growing capabilities in telecom technology.

Ojas64 Unveiled at IMC 2025

Tejas Networks [BSE: 540595, NSE: TEJASNET] has announced the launch of Ojas64, a next-generation 64T64R Massive MIMO (Multiple Input Multiple Output) Radio, at the India Mobile Congress (IMC) 2025 in New Delhi. The unveiling signifies a major step in indigenous telecom technology development.

Key Features and Capabilities

Ojas64 is a best-in-class 5G Macro radio capable of delivering up to 320W of output power with multi-gigabit speeds. It promises double-digit spectral efficiency gains, concurrently aiming to reduce carbon footprint. This product has been fully conceptualized, designed, and manufactured in India.

Leadership Insights

Shri Jyotiraditya Scindia, Hon’ble Union Minister of Communications (MOC) and Development of the North Eastern Region (DoNER), congratulated Tejas Networks. He highlighted the company’s role in setting new technology benchmarks and positioning India as a key player in the design and manufacture of complex Massive MIMO radios for 5G/5G-Advanced networks.

Dr. Kumar N. Sivarajan, CTO and Cofounder of Tejas Networks, expressed pride in the launch of the state-of-the-art, high-performance Massive MIMO radio. He noted that Ojas64 marks a significant milestone in realizing “Atmanirbhar Bharat” in telecom products.

Technology and Standards Compliance

The Ojas64 radio utilizes innovative hardware and software designs, along with patent-pending algorithms, to implement cutting-edge digital beamforming technologies. This enhances network capacity, coverage, and energy efficiency, adhering to global 3GPP and O-RAN standards.

Source: BSE

HFCL Limited ESG Rating of 73 Assigned by CFC Finlease

HFCL Limited has been assigned an Environmental, Social, and Governance (ESG) Rating of ’73’ by CFC Finlease Private Limited. The rating was communicated to HFCL on October 08, 2025. CFC independently prepared the rating report based on data available in the public domain. The rating reflects the company’s commitment to sustainable growth and responsible corporate governance.

ESG Rating Received

HFCL Limited announced that CFC Finlease Private Limited has assigned the company an Environmental, Social, and Governance (ESG) Rating of ’73’. The company received communication of this rating on October 08, 2025.

Rating Details

The ESG rating assigned by CFC Finlease is based on an independent assessment of publicly available data pertaining to HFCL. HFCL stated that it did not engage CFC for this rating. The company believes this rating reflects its dedication towards sustainable growth, environmental stewardship, social responsibility, and sound corporate governance.

Source: BSE

Sun Pharma NCLT Approves Composite Scheme of Arrangement

The National Company Law Tribunal (NCLT) has approved the composite scheme of arrangement involving Sun Pharmaceutical Industries. The scheme includes the amalgamation of wholly-owned subsidiaries with Sun Pharma and the reclassification of the company’s general reserve to retained earnings. This restructuring is effective from April 1, 2023, as the appointed date. The approval was communicated on October 8, 2025.

Amalgamation and Reclassification

Sun Pharmaceutical Industries has received approval from the National Company Law Tribunal (NCLT) for its composite scheme of arrangement. This scheme involves two key components:

  • Amalgamation of wholly-owned subsidiary companies with Sun Pharmaceutical Industries.
  • Reclassification of the company’s general reserve to retained earnings.

Subsidiary Companies Involved

The amalgamation includes the following wholly-owned subsidiaries:

  • Sun Pharmaceutical Medicare Limited
  • Green Eco Development Centre Limited
  • Faststone Mercantile Company Private Limited
  • Realstone Multitrade Private Limited
  • Skisen Labs Private Limited

Effective Date and Financial Impact

The scheme is effective from April 1, 2023. While the announcement does not give specific financial implications of the amalgamation, it is expected to streamline operations and improve financial management. The reclassification of general reserve to retained earnings will change the structure of equity.

Financial Overview of the Companies (2024)

The document provides a snapshot of financials for the year 2024 for both the parent company Sun Pharmaceutical Industries and its subsidiaries. Here’s a look:

Sun Pharmaceutical Medicare Limited

  • Total income: Rs.3,415.1 million
  • Operating profit: Rs.118.4 million
  • Accumulated losses: Rs. 3,835.3 million

Green Eco Development Centre Limited

  • Total income: NIL
  • Loss: Rs. 0.05 million
  • Accumulated losses: Rs. 5.8 million

Faststone Mercantile Company Private Limited

  • Total income: Rs. 0.1 million
  • Operating profit: NIL
  • Reserves: Rs. 3.3 million

Realstone Multitrade Private Limited

  • Total income: Rs. 0.1 million
  • Operating profit: NIL
  • Reserves: Rs. 2.2 million

Skisen Labs Private Limited

  • Total income: NIL
  • Operating profit: NIL
  • Accumulated losses: Rs. 164.2 million

Sun Pharmaceutical Industries Limited

  • Standalone revenue: Rs. 202,751.7 million
  • Consolidated revenue: Rs. 484,968.5 million
  • Standalone net profit: Rs.28,581.8 million
  • Consolidated net profit: Rs. 96,484.4 million
  • Standalone Other equity: Rs.212,929.3 million
  • Consolidated Other equity: Rs. 553,059.1 million

Source: BSE

SBI Card Revises Code of Conduct for Insider Trading

SBI Card has revised its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information, as approved by the Board of Directors on October 8, 2025. The updated code, designed to ensure fair practices and compliance with insider trading regulations, is now available on the company’s website. These revisions aim to enhance transparency and maintain investor confidence.

Revised Insider Trading Code

The Board of Directors of SBI Card has approved revisions to the company’s Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information during its meeting on October 8, 2025. This update is aligned with Regulation 8 of the Securities and Exchange Board of India (SEBI) (Prohibition of Insider Trading) Regulations, 2015.

Key Changes and Disclosures

The revised code aims to govern the disclosure of any information that could materially affect the company’s stock prices. Key points include:

  • Ensuring prompt and uniform disclosure of unpublished price-sensitive information (UPSI).
  • Defining legitimate purposes for sharing UPSI to prevent misuse.
  • Maintaining a digital database of individuals with access to UPSI.
  • Establishing guidelines for communication with analysts and research personnel to prevent selective disclosure.

Availability of the Code

The complete revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information is available on the company’s official website.

Chief Investor Relations Officer

The Chief Financial Officer of SBI Card serves as the Chief Investor Relations Officer (CIRO), responsible for overseeing information dissemination and addressing queries related to market rumors.

Source: BSE

Narayana Hrudayalaya Incorporates Wholly-Owned UK Subsidiary

Narayana Hrudayalaya has announced the incorporation of a wholly-owned step-down subsidiary, Narayana Hrudayalaya UK Ltd., in the United Kingdom. This new entity, formed on October 8, 2025, will be under Health City Cayman Islands Ltd. (HCCI), a wholly-owned overseas subsidiary. The move aims to facilitate potential investments outside of the Cayman Islands and expand the company’s global footprint.

UK Subsidiary Incorporation

Narayana Hrudayalaya has established Narayana Hrudayalaya UK Ltd. as a wholly-owned step-down subsidiary. This incorporation took place on October 8, 2025, under the laws of the United Kingdom. The parent company for this new subsidiary is Health City Cayman Islands Ltd. (HCCI), which is itself a wholly-owned overseas subsidiary of Narayana Hrudayalaya.

Subsidiary Details

Narayana Hrudayalaya UK Ltd. is registered as a private limited company under the Companies Act, 2006 of the United Kingdom. The paid-up share capital is GBP 1000. The new entity will function as a holding company. Currently, since incorporation, it has no turnover.

Strategic Rationale

The formation of the UK subsidiary is intended to explore potential investment opportunities in geographies outside of the Cayman Islands. No governmental or regulatory approvals were required for this incorporation. The entity’s presence is currently limited to the United Kingdom.

Source: BSE

Dr. Agarwal’s Acquisition of Aditya Jyot Eye Hospital Completed

Dr. Agarwal’s Health Care Limited has finalized the acquisition of 41,653 equity shares in Aditya Jyot Eye Hospital Private Limited (AJEHPL). This represents 12.25% of AJEHPL’s equity share capital. The consideration for this transaction amounted to INR 6.25 Crores. As a result of this acquisition, AJEHPL has become a wholly-owned subsidiary of Dr. Agarwal’s.

Acquisition Finalized

Dr. Agarwal’s Health Care Limited announced the completion of the acquisition of Aditya Jyot Eye Hospital Private Limited (AJEHPL) on October 08, 2025. The initial announcement regarding this acquisition was made on August 27, 2025.

Transaction Details

The acquisition involved 41,653 equity shares with a face value of INR 100 each, representing 12.25% of AJEHPL’s equity share capital. The total consideration for this acquisition was INR 6.25 Crores.

Strategic Impact

Following the completion of this transaction, Aditya Jyot Eye Hospital Private Limited (AJEHPL) has become a wholly-owned subsidiary of Dr. Agarwal’s Health Care Limited. This strategic move enhances Dr. Agarwal’s presence and strengthens its position in the eye care sector.

Source: BSE

Oberoi Realty Board to Consider Interim Dividend and Financial Results

Oberoi Realty has announced a board meeting scheduled for October 15, 2025, to consider and approve the unaudited financial results for the quarter ended September 30, 2025 (Q2 FY26). The board will also deliberate on declaring a second interim dividend for the financial year FY25-26 and fix the record date for determining shareholders’ eligibility for the dividend.

Board Meeting Scheduled

Oberoi Realty’s board of directors will convene on October 15, 2025, to discuss key business matters, including the company’s financial performance and potential shareholder payouts.

Financial Results on the Agenda

During the meeting, the board will review and approve the unaudited financial results for the second quarter of the fiscal year 2025-26 (Q2 FY26), which ended on September 30, 2025.

Interim Dividend Consideration

In addition to the financial results, the board will also consider the declaration of a 2nd interim dividend for the fiscal year FY25-26 on the equity shares of the company. The board will also set a record date to determine the eligibility of shareholders for receiving the dividend if declared.

Source: BSE

HFCL Limited Secures Export Orders Worth USD 34.19 Million for Optical Fiber Cables

HFCL Limited has secured export orders worth approximately USD 34.19 million (equivalent to INR 303.35 crore) for the supply of optical fiber cables. The orders will be fulfilled through its overseas wholly-owned subsidiary. These orders reaffirm the trust of global customers in the company’s manufacturing capabilities and product quality. The execution is planned to be completed by April 2026.

Significant Export Order Secured

HFCL Limited announced today that it has secured export orders amounting to roughly USD 34.19 million, which is equivalent to approximately INR 303.35 crore. These orders are for the supply of optical fiber cables (OFC).

Order Details

The orders will be fulfilled through HFCL’s overseas wholly-owned subsidiary and are from a renowned international customer. The order is for the supply of Optical Fiber Cables as per customer specifications. The company expects to complete these orders by April 2026.

Strategic Importance

These export orders highlight the global recognition of HFCL’s manufacturing capabilities, technological excellence, and superior product quality. The company continues to strengthen its position in the international market through its commitment to innovation and customer satisfaction.

Source: BSE

Triveni Turbine Promoter Group Increases Stake Through Internal Transfer

Triveni Turbine has announced that the Promoter Group has increased its stake in the company via an internal transfer. Nikhil Sawhney Trust, part of the Promoter Group, acquired 26.60% shareholding from Ms. Rati Sawhney, another Promoter. This acquisition increases the Trust’s holding in Subhadra Trade and Finance Limited, leading to indirect control over Triveni Turbine. There is no change in company management.

Promoter Group Shareholding Increase

Nikhil Sawhney Trust, a part of Triveni Turbine’s Promoter Group, has acquired a 26.60% shareholding in the company. This acquisition was completed through a transfer from Ms. Rati Sawhney, also a Promoter of the company, who held the shares in Subhadra Trade and Finance Limited.

Details of the Acquisition

The acquired shares were previously held by Ms. Rati Sawhney in Subhadra Trade and Finance Limited (“Subhadra”). Following the acquisition, the Acquirer Trust’s total shareholding in Subhadra has increased to 63.30%. Subhadra presently holds 8,67,24,312 equity shares, which is approximately 27.28% of Triveni Turbine.

Impact on Company Control

As a result of the acquisition, the Acquirer Trust has indirectly acquired control over Triveni Turbine. However, the announcement confirms that there will be no change in the control or management of the company as a result of this transaction.

Rationale for the Transfer

The internal transfer of shares is stated to be in furtherance of an internal reorganization within the Promoter Family. It is intended to streamline succession and promote the welfare of the Promoter Family, ensuring a smooth transition of ownership and management.

Source: BSE

IRB Infrastructure Anil Kumar Yadav Appointed as Chief Executive Officer

IRB Infrastructure Developers Ltd. has announced the promotion of Anil Kumar Yadav to the position of Chief Executive Officer – Business Development & Investment, effective October 8, 2025. Mr. Yadav, previously holding key positions including Group Chief Financial Officer, will also be designated as Key Managerial Personnel of the Company, enhancing IRB’s strategic leadership team. The appointment signifies a strategic move to strengthen business development and investment initiatives.

Executive Leadership Change

Anil Kumar Yadav has been appointed as the Chief Executive Officer – Business Development & Investment at IRB Infrastructure Developers Ltd., effective October 8, 2025. This promotion signifies a strategic decision to strengthen the company’s leadership in key areas.

New Role and Responsibilities

In his new role, Mr. Yadav will lead the Business Development & Investment division. He will also be designated as Key Managerial Personnel. His extensive experience, including his previous role as Group Chief Financial Officer, positions him well to drive IRB’s strategic initiatives.

Executive’s Background

Mr. Yadav is a member of the Institute of Chartered Accountants of India and an alumnus of IIM Ahmedabad. He holds a Bachelor’s degree in Law and a Master’s degree in Commerce from the University of Mumbai. With over 22 years of experience, including 18 years with IRB, he brings a wealth of knowledge in finance, strategy, and corporate leadership to his new role.

Source: BSE